Showing results (601-610 of 9,900) with videos related to

Sort By:
Pageof 990
Bone Marrow Transplantation|August 24, 2010
Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphomaW J Plattel, H C Kluin-Nelemans, G H de Bock, et al.
Bone Marrow Transplantation|September 7, 2010
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapyG J Tack, M J Wondergem, A Al-Toma, et al.
Bone Marrow Transplantation|September 7, 2010
Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMTS Sharma, S Yang, R Rochester, et al.
Bone Marrow Transplantation|November 25, 2010
The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysisG Cook, G H Jackson, G J Morgan, et al.
Bone Marrow Transplantation|October 20, 2010
Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experienceV Lapierre, J-F Rossi, F Heshmati, et al.
Bone Marrow Transplantation|October 1, 1990
Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation modelE Wang, J M Conant, D Li, et al.
Bone Marrow Transplantation|October 1, 1990
Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiationM A Andrykowski, E M Altmaier, R L Barnett, et al.
Bone Marrow Transplantation|November 30, 2010
Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipientsC-Y Liu, Y-C Lai, L-J Huang, et al.
Bone Marrow Transplantation|September 15, 2010
Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCTK Ishiyama, T Katagiri, T Hoshino, et al.
Bone Marrow Transplantation|September 15, 2010
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combinationK Jordan, F Jahn, P Jahn, et al.
Pageof 990